Grant Mitchell — The Potential of AI Drug Rep...

Why has America become so bad at building housing, infrastructure, and major projects? Brian Potter, author of The Origins of Efficiency and writer of Construction Physics, explains why prefab housing keeps failing and why there are no easy fixes to America's building problem. We ...  Show more

What can Aristotle, Plato, Prometheus, and the Greek city-states teach us about AI, innovation, and the future of human flourishing? Alex Petkas joins the show to explore how old myths still matter in a world shaped by technology. We talk about Prometheus as the foundational myth ...  Show more

When Ziad Obermeyer was a resident in an emergency medicine program, he found himself lying awake at night worrying about the complex elements of patient diagnoses that physicians could miss. He subsequently found his way to data science and research and has since coauthored nume ...  Show more

Vaccine-maker Moderna is also a data company, and that’s enabling it to use AI to drastically reduce drug-development times, Chief Information Officer Brad Miller tells Bloomberg Intelligence’s Sam Fazeli and Mandeep Singh. This episode of the Tech Disruptors podcast looks at a w ...  Show more

In this fascinating episode of Brainfluence, pioneering neuromarketer Dr. Carl Marci discusses how modern technology is impacting our brains. He shares insights from his new book Rewired, explaining how excessive smartphone use and constant multitasking are reducing productivi ...

It may seem intuitive that AI and deep learning can speed up workflows — including novel drug discovery, a typically years-long and several-billion-dollar endeavor. But professors Artem Cherkasov and Olexandr Isayev were surprised to find that no recent academic papers provided a ...  Show more